EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark PAIGE.AI was filed as Word mark on 05/31/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/09/2018.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 017911028 |
| Application date | May 31, 2018 |
| Publication date | July 2, 2018 |
| Entry date | October 9, 2018 |
| Expiration date | May 31, 2028 |
Trademark owner
Tata Innovation Center, 11 East Loop Road, Suite 5A
10044 New York
US
10044 New York
US
Trademark representatives
Smaragdweg 2
3817 GM Amersfoort
NL
goods and services
9
Software for use in disease pathology; software for use in diagnosis of diseases, states, or conditions; software for use in evaluation of prognosis relating to diseases, states, or conditions; software for use in monitoring of diseases, states, or conditions; software for use to detect or identify predispositions to diseases, states, or conditions; software for use to detect or determine the recurrence of diseases, states, or conditions; software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software for use in clinical management of diseases, states, or conditions; software for use in the selection of treatment for diseases, states, or conditions; software for use in prevention of diseases, states, or conditions; software for use in palliation or treatment of diseases, states or conditions; software for use in research or development in the field of life sciences; software for use in research or development in the field of medicine; software for use in research or development in the field of healthcare; software for use in research or development in the field of cancer; software for use in research or development in the field of oncology; software for use in research or development in the field of pathology
42
Software as a service (SaaS) services, namely, software for use in disease pathology; software as a service (SaaS) services, namely, software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services, namely, software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services, namely, software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in research or development in the field of life sciences; software as a service (SaaS) services, namely, software for use in research or development in the field of medicine; software as a service (SaaS) services, namely, software for use in research or development in the field of healthcare; software as a service (SaaS) services, namely, software for use in research or development in the field of cancer; software as a service (SaaS) services, namely, software for use in research or development in the field of oncology; software as a service (SaaS) services, namely, software for use in research or development in the field of pathology; design and development of computer software and artificial intelligence; medical research; research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical and scientific research information via the internet; electronic scanning of clinical pathology slides; analysis of clinical pathology slides; medical and scientific testing services for research purposes
44
Medical services; cancer therapy services; medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 2, 2023 | Change Representative, Published | ||
| January 28, 2021 | Change Representative, Published | ||
| January 7, 2021 | RAW: Representative - Deletion of the representative, Published | ||
| July 9, 2020 | Change Representative, Published | ||
| November 12, 2019 | Change Representative, Published |
ID: 11017911028